Compare MREO & AGIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MREO | AGIG |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 63.5M |
| IPO Year | 2017 | N/A |
| Metric | MREO | AGIG |
|---|---|---|
| Price | $0.42 | $3.28 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.90 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 930.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.20 | $1.37 |
| 52 Week High | $2.94 | $4.89 |
| Indicator | MREO | AGIG |
|---|---|---|
| Relative Strength Index (RSI) | 37.72 | 60.81 |
| Support Level | $0.35 | $2.80 |
| Resistance Level | $0.44 | $4.89 |
| Average True Range (ATR) | 0.05 | 0.41 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 62.96 | 57.01 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Abundia Global Impact Group Inc is a technology solutions company that operates in the recycling and renewable energy, environmental change, fuels and chemicals sectors. The company focuses on using waste products to decarbonize the energy, fuels and chemicals sector by providing renewable or recycled alternatives.